Jpmorgan Chase & Co »

Oramed Pharm shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Oramed Pharm (ORMP) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Oramed Pharm

Tip: Access up to 7 years of quarterly data

All positions including Oramed Pharm held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Oramed Pharm by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2025-09-30 $449 170 2.64
2024-06-30 $18k 6.9k 2.57
2024-03-31 $33k 11k 2.92
2023-12-31 $66k 29k 2.31
2023-09-30 $120k 46k 2.61
2023-06-30 $193k 54k 3.58
2023-03-31 $378k 174k 2.17
2022-12-31 $4.9M 405k 12.00
2022-06-30 $1.5M 337k 4.58
2022-03-31 $191k 18k 10.75
2021-12-31 $546k 35k 15.63
2020-06-30 $0 13 0.00
2020-03-31 $9.0k 3.0k 3.00
2017-12-31 $15k 1.7k 8.82
2016-06-30 $0 10 0.00